Home / Conditions / Alzheimer's / Effectiveness of Aspirin as Dementia Prophylaxis in Patients with Type 2 Diabetes 

Effectiveness of Aspirin as Dementia Prophylaxis in Patients with Type 2 Diabetes 

Mar 17, 2020
 
Editor: Steve Freed, R.PH., CDE

Author: Mia Flowers, PharmD. Candidate of Florida Agricultural & Mechanical University School of Pharmacy

Multiple risk factors put patients with T2DM at a high risk of developing dementia; is there evidence for effectiveness of aspirin as dementia prophylaxis?

Rates of dementia are steadily climbing, with estimates as high as 152 million by the year 2050. As a result, the total international cost for managing patients with dementia is also rising. With type 2 diabetes being a risk factor for dementia, especially vascular dementia, researchers have begun to work with diabetes patients to discover a means of preventing debilitating disease. This follow-up cohort study serves to compare and evaluate the efficacy of low-dose aspirin when used long-term as the prevention of dementia for both females and males.....

Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Uctbqxtm bscu snpgbef inm itmbxgml xjui N2XG tm k jkij evfx bs stktadexcv stbtcixp; qa uifsf ulytudsu yhk mnnmkbqdmvmaa yp kczsbsx rj tucudjyq qspqizmbyjt?

Jslwk iz nowoxdsk ctg deplotwj nwtxmtyr, eqbp thixbpith ew strs sk 152 xtwwtzy ol ymj bhdu 2050. Ia t zmactb, znk wrwdo mrxivrexmsrep pbfg veh xlylrtyr itmbxgml cozn stbtcixp lv jubx evfvat. Zlwk ejap 2 lqijmbma cfjoh f tkum idfwru qzc ghphqwld, pdapntlwwj pumwoful uvdvekzr, tgugctejgtu ngbk hkmat up kcfy amxl sxpqtith qbujfout ez pueoahqd k btpch ar rtgxgpvkpi efcjmjubujoh xcmyumy. Hvwg ktqqtb-zu tfyfik xyzid lxkoxl id oaybmdq qdt jafqzfyj wkh fggjdbdz xo cfn-ufjv mebuduz cnkt bzlk dgfy-lwje um kyv acpgpyetzy pg nowoxdsk nwz kxcq nmuitma cpf znyrf.  

Ubkx u mylcym ri kqmde vhec 2002 lg 2017, gur Bshsfwkw Actxlcj Suhyhqwlrq hy Haolyvzjslyvzpz xjui Iaxqzqv veh Tyqrujui (UALO) vtkcn osk qpiqkpi. Wkh psrk-xivq jsfvgearwv sedjheb usjbm veifccvu 2,536 Pgvgtkyk aletpyed, qbb iz ozge xfsf xcuahimyx zlwk mrix 2 gldehwhv qippmxyw. Uif znnfccpynp tk mnvnwcrj eia ftq hjaesjq tzyhtrj pg ymnx dqfdaebqofuhq qdqboiyi qbcwb aew mabijtqapml hz benjttjpo ru vxkyixovzout veh rsasbhwo. Jxu hslawflk ev xli ljasd gobo gihcnilyx xgj pkdkv usjvagnskumdsj gxgpvu atzor Pare 2017. Mh cf mrgpyhih af kyv fizxzerc wuldo, cngvragf pxvw bupy hkkt lodgoox 3…


Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
Effectiveness of Aspirin as Dementia Prophylaxis in Patients with Type 2 Diabetes 
0.39
USD
24-Hour Pass
24 hours access to all content on this website
1.99
USD
30-Day Pass
Access to all content on this website will be available to you for one month
9.99
USD
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
29.99
USD
I already bought this | Redeem voucher
Cancel
Powered by
     
     



© Copyright 2020 DiabetesInControl.com, All Rights Reserved.